TCR2 Therapeutics Inc.
TCRRDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001750019
TCR2 Therapeutics Inc. was delisted in 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.7M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by TCR2 Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for TCR2 Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Tang Kevin C | 10% Owner | 0Indirect | Feb 14, 2024 | 0 |
| Tang Capital Partners LP | 10% Owner | 0Indirect | Feb 14, 2024 | 0 |
| Tang Capital Management LLC | 10% Owner | 0Indirect | Feb 14, 2024 | 0 |
| MPM BioImpact LLC | 10% Owner | 0 | Jun 5, 2023 | 0 |
| UBS Oncology Impact Fund L.P. | 10% Owner | 0 | Jun 5, 2023 | 0 |
| Oncology Impact Fund (Cayman) Management L.P. | 10% Owner | 0 | Jun 5, 2023 | 0 |
| MPM SunStates Fund, L.P. | 10% Owner | 0Indirect | Jun 5, 2023 | 0 |
| MPM SunStates GP Managing Member LLC | 10% Owner | 0Indirect | Jun 5, 2023 | 0 |
| MPM Asset Management Investors SunStates Fund LLC | 10% Owner | 0Indirect | Jun 5, 2023 | 0 |
| MPM SunStates Fund GP LLC | 10% Owner | 0Indirect | Jun 5, 2023 | 0 |
| Evnin Luke | 10% Owner | 0Indirect | Jun 5, 2023 | 0 |
| MPM Asset Management LLC | 10% Owner | 0Indirect | Jun 5, 2023 | 0 |
| Foley Todd | 10% Owner | 0Indirect | Jun 5, 2023 | 0 |
| MPM BioVentures 2014, L.P. | 10% Owner | 0Indirect | Jun 5, 2023 | 0 |
| MPM BioVentures 2014 (B), L.P. | 10% Owner | 0Indirect | Jun 5, 2023 | 0 |
| MPM Asset Management Investors BV2014 LLC | 10% Owner | 0Indirect | Jun 5, 2023 | 0 |
| MPM BioVentures 2014 LLC | 10% Owner | 0Indirect | Jun 5, 2023 | 0 |
| MPM BioVentures 2014 GP LLC | 10% Owner | 0Indirect | Jun 5, 2023 | 0 |
| Gadicke Ansbert | Director, 10% Owner | 0Indirect | Jun 5, 2023 | 0 |
| Allen Andrew R | Director | – | Jun 1, 2023 | 0 |
| Webster Stephen W | Director | – | Jun 1, 2023 | 0 |
| Gibson Neil W | Director | – | Jun 1, 2023 | 0 |
| Menzel Garry E | President and CEO | 0 | Jun 1, 2023 | 0 |
| Sullivan Eric | Chief Financial Officer | – | Jun 1, 2023 | 0 |
| Tomasello Shawn | Director | – | Jun 1, 2023 | 0 |
| Justice Angela | Chief People Officer | 0 | Jun 1, 2023 | 0 |
| Cardama Alfonso Quintas | Chief Medical Officer | 0 | Jun 1, 2023 | 0 |
| Hoos Axel | Director | – | Jun 1, 2023 | 0 |
| Harrison Rosemary | Chief Business & Strategy | – | Jun 1, 2023 | 0 |
| Olagunju Peter | Chief Operating Officer | 0 | Jun 1, 2023 | 0 |
| Hegde Priti | Director | – | Jun 1, 2023 | 0 |
| Hofmeister Robert | Chief Scientific Officer | – | Dec 10, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 30, 2023 (view filing)8:02 PM ET | May 25 | 5 days | Tang Kevin C and 2 others10% Owner | PPurchase | +50.0K | $1.72 | +$86.0K | +1.2%4.39M after | |
| May 24, 2023 (view filing)4:39 PM ET | May 22 | 2 days | Evnin Luke and 1 other10% Owner | SSale | −70.2K | $1.88 | −$131.9K | −18.8%304.0K after | Duplicate filing |
| May 24, 2023 (view filing) | May 22 | 2 days | Gadicke AnsbertDirector, 10% Owner | SSale | −70.2K | $1.88 | −$131.9K | −18.8%304.0K after | |
| May 15, 2023 (view filing)5:12 PM ET | May 11-12 | 4 days | Tang Kevin C and 2 others10% Owner | PPurchase | +44.9K | $1.95 | +$87.6K | +1.0%4.34M after | 2 lots |
| May 10, 2023 (view filing)7:02 PM ET | May 8-10 | 2 days | Tang Kevin C and 2 others10% Owner | PPurchase | +84.0K | $1.95 | +$163.8K | +2.0%4.30M after | 3 lots |
| May 5, 2023 (view filing)6:52 PM ET | May 3-5 | 2 days | Tang Kevin C and 2 others10% Owner | PPurchase | +289.6K | $1.89 | +$547.9K | +7.4%4.22M after | 4 lots |
| Dec 13, 2022 (view filing) | Dec 9-13 | 4 days | Cardama Alfonso QuintasChief Medical Officer | SSale | −13.8K | $1.10 | −$15.1K | −11.2%109.5K after | 3 lots |
| Dec 13, 2022 (view filing) | Dec 9-13 | 4 days | Olagunju PeterChief Technical Officer | SSale | −4.83K | $1.10 | −$5.31K | −16.7%24.1K after | 3 lots |
| Dec 13, 2022 (view filing) | Dec 9-12 | 4 days | Justice AngelaChief People Officer | SSale | −8.62K | $1.10 | −$9.45K | −15.0%48.7K after | 3 lots |
| Dec 13, 2022 (view filing) | Dec 9-13 | 4 days | Menzel Garry EPresident and CEO | SSale | −31.9K | $1.10 | −$35.0K | −18.7%138.9K after | 3 lots |
| Dec 9, 2022 (view filing) | Dec 7-8 | 2 days | Cardama Alfonso QuintasChief Medical Officer | SSale | −7.94K | $1.27 | −$10.1K | −6.1%123.3K after | 2 lots |
| Dec 9, 2022 (view filing) | Dec 7-8 | 2 days | Menzel Garry EPresident and CEO | SSale | −18.4K | $1.26 | −$23.3K | −9.7%170.8K after | 2 lots |
| Dec 9, 2022 (view filing) | Dec 7-8 | 2 days | Justice AngelaChief People Officer | SSale | −4.97K | $1.27 | −$6.31K | −8.0%57.4K after | 2 lots |
| Dec 9, 2022 (view filing) | Dec 7-8 | 2 days | Olagunju PeterChief Technical Officer | SSale | −2.79K | $1.26 | −$3.53K | −8.8%28.9K after | 2 lots |
| Dec 7, 2022 (view filing) | Dec 5-6 | 2 days | Cardama Alfonso QuintasChief Medical Officer | SSale | −7.46K | $1.35 | −$10.1K | −5.4%131.2K after | 2 lots |
| Dec 7, 2022 (view filing) | Dec 5-6 | 2 days | Olagunju PeterChief Technical Officer | SSale | −2.62K | $1.35 | −$3.53K | −7.6%31.7K after | 2 lots |
| Dec 7, 2022 (view filing) | Dec 5-6 | 2 days | Menzel Garry EPresident and CEO | SSale | −23.4K | $1.36 | −$31.8K | −11.0%189.2K after | 2 lots |
| Dec 7, 2022 (view filing) | Dec 5-6 | 2 days | Justice AngelaChief People Officer | SSale | −4.66K | $1.35 | −$6.29K | −7.0%62.3K after | 2 lots |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Cardama Alfonso QuintasChief Medical Officer | SSale | −3.64K | $1.39 | −$5.05K | −2.6%138.7K after | |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Olagunju PeterChief Technical Officer | SSale | −1.27K | $1.39 | −$1.77K | −3.6%34.3K after | |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Menzel Garry EPresident & CEO | SSale | −8.41K | $1.39 | −$11.7K | −3.8%212.7K after | |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Justice AngelaChief People Officer | SSale | −2.27K | $1.39 | −$3.16K | −3.3%67.0K after |